JIA-Associated Uveitis: Screening Schedule and Treatment
Last updated: November 2026
Uveitis in juvenile idiopathic arthritis (JIA) is chronic, anterior and usually painless: the eye looks white while band keratopathy, cataract and glaucoma develop. Regular screening is the only way to catch it early.
Who is at highest risk?
- Oligoarticular (few joint) JIA.
- Positive antinuclear antibody (ANA).
- Onset of arthritis at age 6 or younger.
- The first 4 years after arthritis onset.
- Systemic-onset JIA rarely causes uveitis; enthesitis-related JIA (HLA-B27) causes acute painful uveitis.
Screening schedule (AAP/AAO approach)
| Risk | Example | Slit lamp every |
|---|---|---|
| High | Oligo- or RF-negative polyarthritis, ANA positive, onset at 6 or younger, within 4 years of onset | 3 months |
| Moderate | ANA positive with older onset or longer duration, or ANA negative with onset at 6 or younger | 6 months |
| Low | Others, and after 7 years of disease | 12 months |
Schedules vary slightly between guidelines; follow your rheumatology unit's protocol.
Signs and complications
- Cells and flare in a white eye, small KPs, posterior synechiae.
- Band keratopathy, cataract (also from steroids), glaucoma or hypotony, macular oedema, amblyopia in young children.
Treatment
- Topical steroids with the aim of zero cells; minimise long-term steroid use (cataract and glaucoma).
- Methotrexate first-line systemically; adalimumab added if uveitis persists (SYCAMORE trial: treatment failure fell from 60% to 27%).
- Cataract surgery only after at least 3 months of quiet eyes, with peri-operative immunosuppression; IOL implantation is now possible in selected children.
Where residents slip
- Waiting for a red, painful eye: JIA uveitis is silent.
- Stopping screening once the arthritis settles.
- Operating on a cataract before the eye has been quiet for 3 months.
Test yourself: flip cards
Related: Uveitis Made Easy: SUN Terms, Patterns and Work-up, Congenital Cataract: Timing & Management, Landmark Trials in Ophthalmology: High-Yield Summary.
Key sources
- Angeles-Han ST, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the screening, monitoring and treatment of JIA-associated uveitis. Arthritis Care Res. 2019;71:703-716
- Ramanan AV, et al. Adalimumab plus methotrexate for uveitis in JIA. N Engl J Med. 2017;376:1637-1646
📘 Want more exam-ready material? See Most Commons in Ophthalmology on Kindle, or browse all my books.
Looking for an eye specialist in Ahmedabad? Learn about our Eye Department or book a consultation with Dr. Dhaval Patel.